Karyopharm Therapeut
(KPTI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 12-2011 | |
| Sales | 233 | 0 | 34 | 0 | 0 |
| Gross Profit | 233 | N/A | 34 | 0 | N/A |
| Operating Expenses | 5,844 | 0 | 3,669 | 0 | 0 |
| Operating Income | -5,611 | N/A | -3,635 | N/A | N/A |
| Pre-tax Income | -5,611 | 0 | -3,635 | 0 | 0 |
| Net Income Continuous | -5,611 | N/A | -3,635 | 0 | N/A |
| Net Income | $-5,611 | $N/A | $-3,635 | $0 | $N/A |
| EPS Basic Total Ops | -37.78 | N/A | -29.54 | N/A | N/A |
| EPS Basic Continuous Ops | -37.79 | N/A | -29.51 | N/A | N/A |
| EPS Diluted Total Ops | -37.78 | N/A | -29.54 | N/A | N/A |
| EPS Diluted Continuous Ops | -37.79 | N/A | -29.51 | N/A | N/A |
| EBITDA(a) | $-5,577 | $N/A | $-3,601 | $N/A | $N/A |